February 10, 2026
Moderna says FDA refuses its application for new mRNA flu vaccine
The U.S. Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
TL;DR
- The FDA has refused to consider Moderna's application for a new flu vaccine.
- The vaccine is made using mRNA technology, which won a Nobel Prize.
- Moderna announced the FDA's decision on Tuesday.
Continue reading the original article